Skip to main content

Advertisement

Springer Nature Link
Log in

CircGLIS3 inhibits thyroid cancer invasion and metastasis through miR-146b-3p/AIF1L axis

  • Research
  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Purpose

Studies have shown that circRNA is involved in the occurrence and development of human cancers. However, it remains unclear that the contribution of circRNA in thyroid carcinoma and its role in the process of tumorigenesis.

Methods

The expression profile of circRNA-miRNA-mRNA in thyroid carcinoma was detected by RNA sequencing and verified by qRT-PCR. The characteristics of circGLIS3 were verified by RNase R and actinomycin assays, subcellular fractionation, and fluorescence in situ hybridization. The functions of circGLIS3 and AIF1L were detected by wound healing, transwell, 3D culture and Western blot. RNA Immunoprecipitation (RIP), RNA pulldown and dual-luciferase reporter assays were used to verify the target genes of circGLIS3 and downstream miRNAs. Functional rescue experiments were performed by transfecting miRNA mimics or siRNA of target genes. Finally, metastatic mouse models were used to investigate circGLIS3 function in vivo.

Results

In this study, we discovered a novel circRNA (has_circ_0007368, named as circGLIS3) by RNA sequencing. CircGLIS3 was down-regulated in thyroid carcinoma tissues and cells line, and was negatively associated with malignant clinical features of thyroid carcinoma. Functional studies found that circGLIS3 could inhibit the migration and invasion of thyroid carcinoma cells, and was related to the EMT process. Mechanistically, circGLIS3 can upregulate the expression of the AIF1L gene by acting as a miR-146b-3p sponge to inhibit the progression of thyroid carcinoma.

Conclusion

Our study identified circGLIS3 as a novel tumor suppressor in thyroid cancer, indicating the potential of circGLIS3 as a promising diagnostic and prognostic marker for thyroid cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data Availability

The data in the present study is available from the corresponding author upon reasonable request.

Abbreviations

DTC:

Differentiated thyroid carcinoma

circRNAs:

Circular RNAs

EMT:

Epithelial-mesenchymal transition

RBPs:

RNA binding proteins

PTC:

Papillary thyroid carcinoma

ceRNA:

Competing endogenous RNA

ATC:

Anaplastic thyroid carcinoma

FBS:

Fetal bovine serum

NC:

Negative control

FISH:

Fluorescence in situ hybridization

3D:

Three-dimensional

RIP:

RNA immunoprecipitation

SD:

Standard deviation

gDNA:

Genomic DNA

AIF1L:

Allograft inflammatory factor 1 like

IBA2:

Ionized calcium-binding adapter molecule 2

AIF1:

Allograft inflammatory factor 1

References

  1. Siegel, R.L., et al., Cancer Statistics, 2021. CA Cancer J Clin 71(1), 7-33 (2021)

  2. L. Shobab, K.D. Burman, L. Wartofsky, Sex differences in differentiated thyroid Cancer. Thyroid. 32(3), 224–235 (2022)

    Article  CAS  PubMed  Google Scholar 

  3. I.C. Huang et al., Long-term outcomes of distant metastasis from differentiated thyroid carcinoma. Clin. Endocrinol. (Oxf). 76(3), 439–447 (2012)

    Article  CAS  PubMed  Google Scholar 

  4. M. Xing, Molecular pathogenesis and mechanisms of thyroid cancer. Nat. Rev. Cancer. 13(3), 184–199 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. R. Liu et al., Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer. Nat. Commun. 9(1), 579 (2018)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. L.S. Kristensen et al., The biogenesis, biology and characterization of circular RNAs. Nat. Rev. Genet. 20(11), 675–691 (2019)

    Article  CAS  PubMed  Google Scholar 

  7. S. Memczak et al., Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495(7441), 333–338 (2013)

    Article  CAS  PubMed  Google Scholar 

  8. L.S. Kristensen et al., The emerging roles of circRNAs in cancer and oncology. Nat. Rev. Clin. Oncol. 19(3), 188–206 (2022)

    Article  CAS  PubMed  Google Scholar 

  9. Y. Liu et al., Circular RNA circGlis3 protects against islet β-cell dysfunction and apoptosis in obesity. Nat. Commun. 14(1), 351 (2023)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. S. Qu et al., The emerging functions and roles of circular RNAs in cancer. Cancer Lett. 414, 301–309 (2018)

    Article  CAS  PubMed  Google Scholar 

  11. X. Peng et al., Circular RNA_0057209 Acts as ceRNA to Inhibit Thyroid Cancer Progression by Promoting the STK4-Mediated Hippo Pathway via Sponging MicroRNA-183. Oxid. Med. Cell. Longev., 9974639 (2022).

  12. B.M. Shifman et al., Circular RNAs and thyroid cancer: closed molecules, open possibilities. Crit. Rev. Oncol. Hematol. 173, 103662 (2022)

    Article  PubMed  Google Scholar 

  13. Q. Zhang et al., Hsa_circ_0023990 promotes Tumor Growth and Glycolysis in Dedifferentiated TC via Targeting miR-485-5p/FOXM1 Axis. Endocrinology 162(12) (2021)

  14. W. Yu et al., The combination of circRNA-UMAD1 and Galectin-3 in peripheral circulation is a co-biomarker for predicting lymph node metastasis of thyroid carcinoma. Am. J. Transl Res. 12(9), 5399–5415 (2020)

    CAS  PubMed  PubMed Central  Google Scholar 

  15. E. Anastasiadou, L.S. Jacob, F.J. Slack, Non-coding RNA networks in cancer. Nat. Rev. Cancer 18(1), 5–18 (2018)

    Article  CAS  PubMed  Google Scholar 

  16. Z. Luo, R.N.A. Circular et al., circCCDC9 acts as a mir-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression. Mol. Cancer 19(1), 86 (2020)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Z. Cheng et al., circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat. Commun. 10(1), 3200 (2019)

    Article  PubMed  PubMed Central  Google Scholar 

  18. X. Guo et al., Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. Mol. Cancer. 19(1), 83 (2020)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. H. Liu et al., circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis. Theranostics. 10(23), 10791–10807 (2020)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. L. Chen et al., The bioinformatics toolbox for circRNA discovery and analysis. Brief. Bioinform. 22(2), 1706–1728 (2021)

    Article  CAS  PubMed  Google Scholar 

  21. C. Xu, J. Zhang, Mammalian circular RNAs result largely from splicing errors. Cell. Rep. 36(4), 109439 (2021)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. T. Aktaş et al., DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome. Nature. 544(7648), 115–119 (2017)

    Article  PubMed  Google Scholar 

  23. L. Salmena et al., A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 146(3), 353–358 (2011)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. C.K. Chou et al., miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation. Thyroid 20(5), 489–494 (2010)

    Article  CAS  PubMed  Google Scholar 

  25. M.V. Geraldo, A.S. Yamashita, E.T. Kimura, MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. Oncogene 31(15), 1910–1922 (2012)

    Article  CAS  PubMed  Google Scholar 

  26. X. Deng et al., MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3. Cell. Physiol. Biochem. 35(1), 71–82 (2015)

    Article  CAS  PubMed  Google Scholar 

  27. C. Yu et al., MicroRNA-146b-3p promotes cell metastasis by directly targeting NF2 in human papillary thyroid Cancer. Thyroid 28(12), 1627–1641 (2018)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. G. Riesco-Eizaguirre et al., The miR-146b-3p/PAX8/NIS Regulatory Circuit modulates the differentiation phenotype and function of thyroid cells during carcinogenesis. Cancer Res. 75(19), 4119–4130 (2015)

    Article  CAS  PubMed  Google Scholar 

  29. S. Hou et al., Downregulation of miR-146b-3p inhibits Proliferation and Migration and modulates the expression and location of Sodium/Iodide Symporter in dedifferentiated thyroid Cancer by potentially targeting MUC20. Front. Oncol. 10, 566365 (2020)

    Article  PubMed  Google Scholar 

  30. J.O. Schulze et al., Structural and functional characterization of human iba proteins. FEBS J. 275(18), 4627–4640 (2008)

    Article  CAS  PubMed  Google Scholar 

  31. R. Donato, S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell. Biol. 33(7), 637–668 (2001)

    Article  CAS  PubMed  Google Scholar 

  32. M. Yasuda-Yamahara et al., AIF1L regulates actomyosin contractility and filopodial extensions in human podocytes. PLoS One 13(7), e0200487 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  33. P. Liu et al., Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer. Onco Targets Ther. 11, 5485–5498 (2018)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Y. Zhang, S. Wang, L. Li, E.F. Hand Protein, IBA2 promotes cell proliferation in breast cancers via Transcriptional Control of Cyclin D1. Cancer Res. 76(15), 4535–4545 (2016)

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was funded by the National Natural Science Foundation of China (No.81772850 and No.82273300) and Medical Science and Technology Research Fund of Guangdong Province (A2021127).

Author information

Author notes

  1. Siting Cao and Yali Yin contributed equally to this work.

Authors and Affiliations

  1. Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China

    Siting Cao, Huijuan Hu, Shubin Hong, Weiman He, Yanbing Li, Shuang Yu & Haipeng Xiao

  2. Department of Endocrinology, Peking University Shenzhen Hospital, Shenzhen, 518036, China

    Yali Yin

  3. Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China

    Weiming Lv

  4. Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    Rengyun Liu

Authors
  1. Siting Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yali Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huijuan Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shubin Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Weiman He
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Weiming Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rengyun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yanbing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shuang Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Haipeng Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S.C. and Y.Y. performed the experiments and drafted the manuscript; H.H. and W.H. provided experimental support; W.L. collected the clinical specimens; S.H., R.L. and Y.L. commented on the study; S.Y. and H.X. designed and supervised the study and revised the manuscript. All authors reviewed the manuscript.

Corresponding authors

Correspondence to Shuang Yu or Haipeng Xiao.

Ethics declarations

Ethics approval and consent to participate

The study, which involved human samples, obtained approval from the Institutional Research Ethics Committee of Sun Yat-sen University. Animal Experiment were carried out in accordance with the National Research Council’s Guide for the Care and Use of Laboratory Animals and were conducted with the approval of the Ethics Committee of Sun Yat-sen University.

Competing interests

The authors declare no potential conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cao, S., Yin, Y., Hu, H. et al. CircGLIS3 inhibits thyroid cancer invasion and metastasis through miR-146b-3p/AIF1L axis. Cell Oncol. 46, 1777–1789 (2023). https://doi.org/10.1007/s13402-023-00845-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-023-00845-2

Keywords

Search

Navigation